The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle. (Q46924901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Claudio Cabello-Verrugio

object named as

Claudio Cabello-Verrugio

8

1 reference

ORCID Public Data File 2021

author name string

María Gabriela Morales

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Carla Meneses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Felipe Simon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Franco Cisternas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Juan Carlos Rivera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yaneisi Vazquez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

1 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

251-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Renin-angiotensin system revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin II and renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin II: role in skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Protein kinase C-mediated phosphorylation of p47 phox modulates platelet-derived growth factor-induced H2O2 generation and cell proliferation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) as an antihypertensive, antifibrotic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1–7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: Role of MMPs/TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Redox mechanisms of muscle dysfunction in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

The contribution of reactive oxygen species to sarcopenia and muscle ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130585

21 January 2018

Identifiers

DOI

10.1042/CS20130585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24588264%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference